Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$53.86 - $66.52 $602,908 - $744,624
11,194 New
11,194 $619,000
Q1 2022

Apr 26, 2022

SELL
$62.86 - $69.24 $876,331 - $965,274
-13,941 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$62.47 - $73.25 $870,894 - $1.02 Million
13,941 New
13,941 $969,000
Q3 2021

Oct 21, 2021

SELL
$64.97 - $76.19 $273,653 - $320,912
-4,212 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$66.79 - $76.63 $281,319 - $322,765
4,212 New
4,212 $287,000
Q1 2021

May 12, 2021

SELL
$62.63 - $71.15 $789,325 - $896,703
-12,603 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$43.31 - $66.55 $545,835 - $838,729
12,603 New
12,603 $811,000
Q3 2020

Nov 02, 2020

SELL
$43.33 - $51.72 $451,845 - $539,336
-10,428 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$41.42 - $55.57 $431,927 - $579,483
10,428 New
10,428 $486,000
Q1 2020

Apr 17, 2020

SELL
$36.67 - $61.04 $158,744 - $264,242
-4,329 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$55.73 - $62.49 $241,255 - $270,519
4,329 New
4,329 $252,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.